| Product Code: ETC7188454 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Fiji`s vaccine contract manufacturing import shipments continued to be dominated by key suppliers including New Zealand, USA, Australia, India, and Taiwan, Province of China. Despite a significant decline in the compound annual growth rate (CAGR) from 2020-24 at -57.08%, the high Herfindahl-Hirschman Index (HHI) indicates a concentrated market. The growth rate for 2023-24 also saw a steep decline at -57.1%. Overall, the import dynamics suggest a stable but concentrated market environment for vaccine contract manufacturing in Fiji.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Vaccine Contract Manufacturing Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Vaccine Contract Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Fiji Vaccine Contract Manufacturing Market - Industry Life Cycle |
3.4 Fiji Vaccine Contract Manufacturing Market - Porter's Five Forces |
3.5 Fiji Vaccine Contract Manufacturing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Fiji Vaccine Contract Manufacturing Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Fiji Vaccine Contract Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for vaccines in Fiji due to rising awareness about preventive healthcare |
4.2.2 Government initiatives to improve healthcare infrastructure and accessibility in Fiji |
4.2.3 Growth in research and development activities related to new vaccines and treatments |
4.3 Market Restraints |
4.3.1 Limited funding allocated to healthcare and vaccine manufacturing in Fiji |
4.3.2 Lack of skilled workforce and advanced manufacturing facilities |
4.3.3 Regulatory challenges and compliance requirements in vaccine manufacturing |
5 Fiji Vaccine Contract Manufacturing Market Trends |
6 Fiji Vaccine Contract Manufacturing Market, By Types |
6.1 Fiji Vaccine Contract Manufacturing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Fiji Vaccine Contract Manufacturing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Fiji Vaccine Contract Manufacturing Market Revenues & Volume, By Fill-Finish, 2021- 2031F |
6.1.4 Fiji Vaccine Contract Manufacturing Market Revenues & Volume, By Bulk Product, 2021- 2031F |
6.2 Fiji Vaccine Contract Manufacturing Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Fiji Vaccine Contract Manufacturing Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.2.3 Fiji Vaccine Contract Manufacturing Market Revenues & Volume, By Biotech Companies, 2021- 2031F |
6.2.4 Fiji Vaccine Contract Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
7 Fiji Vaccine Contract Manufacturing Market Import-Export Trade Statistics |
7.1 Fiji Vaccine Contract Manufacturing Market Export to Major Countries |
7.2 Fiji Vaccine Contract Manufacturing Market Imports from Major Countries |
8 Fiji Vaccine Contract Manufacturing Market Key Performance Indicators |
8.2 Number of new partnerships or collaborations in vaccine manufacturing sector in Fiji |
8.3 Percentage growth in the number of trained professionals in vaccine manufacturing industry in Fiji |
9 Fiji Vaccine Contract Manufacturing Market - Opportunity Assessment |
9.1 Fiji Vaccine Contract Manufacturing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Fiji Vaccine Contract Manufacturing Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Fiji Vaccine Contract Manufacturing Market - Competitive Landscape |
10.1 Fiji Vaccine Contract Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Fiji Vaccine Contract Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |